1. Home
  2. SIMO vs NTLA Comparison

SIMO vs NTLA Comparison

Compare SIMO & NTLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Silicon Motion Technology Corporation

SIMO

Silicon Motion Technology Corporation

HOLD

Current Price

$117.30

Market Cap

3.2B

Sector

Technology

ML Signal

HOLD

Logo Intellia Therapeutics Inc.

NTLA

Intellia Therapeutics Inc.

HOLD

Current Price

$14.46

Market Cap

986.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SIMO
NTLA
Founded
1995
2014
Country
Hong Kong
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.2B
986.9M
IPO Year
2005
2016

Fundamental Metrics

Financial Performance
Metric
SIMO
NTLA
Price
$117.30
$14.46
Analyst Decision
Strong Buy
Buy
Analyst Count
9
19
Target Price
$105.00
$17.32
AVG Volume (30 Days)
728.3K
5.9M
Earning Date
02-03-2026
02-26-2026
Dividend Yield
1.77%
N/A
EPS Growth
8.75
N/A
EPS
2.87
N/A
Revenue
$798,326,000.00
$57,528,000.00
Revenue This Year
$10.15
$1.96
Revenue Next Year
$16.36
N/A
P/E Ratio
$39.43
N/A
Revenue Growth
N/A
33.52
52 Week Low
$37.21
$5.90
52 Week High
$127.67
$28.25

Technical Indicators

Market Signals
Indicator
SIMO
NTLA
Relative Strength Index (RSI) 65.46 69.73
Support Level $111.00 $13.86
Resistance Level $127.67 $15.95
Average True Range (ATR) 8.57 1.24
MACD -0.01 0.39
Stochastic Oscillator 59.95 65.30

Price Performance

Historical Comparison
SIMO
NTLA

About SIMO Silicon Motion Technology Corporation

Silicon Motion Technology Corp is engaged in developing NAND flash controllers for SSDs and other solid state storage devices. Its only operating segment is to develop NAND flash controllers and SSDs solutions. The company derives revenue from product categories such as Mobile Storage, Mobile Communications, and others. Silicon's geographical segments are Taiwan, the United States, Korea, China, Singapore, Malaysia, and others. The company products are used in Personal Computing, Smartphone/Tablet/CE, Flash Card/USB Flash Drive, Industrial and Embedded, Automotive, and Enterprise and Data centers.

About NTLA Intellia Therapeutics Inc.

Intellia Therapeutics is a gene-editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. Intellia is focused on using this technology to treat genetically defined diseases. It's evaluating multiple gene editing approaches using in vivo and ex vivo therapies to address diseases with high unmet medical needs, including ATTR amyloidosis, hereditary angioedema, sickle cell disease, and immuno-oncology. Intellia has formed collaborations with several companies to advance its pipeline, including narrow-moat Regeneron and wide-moat Novartis.

Share on Social Networks: